⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5695351 | 0.97 | — | — | |
| SCHEMBL7739600 | 0.97 | — | — | |
| SCHEMBL6974870 | 0.97 | — | — | |
| SCHEMBL7738671 | 0.97 | — | — | |
| SCHEMBL602295 | 0.90 | — | — | |
| SCHEMBL9170284 | 0.69 | — | — | |
| SCHEMBL18931046 | 0.69 | ALDH1A1 (0.39) | — | |
| SCHEMBL100581 | 0.62 | — | — | |
| SCHEMBL5244074 | 0.62 | — | — | |
| SCHEMBL65251 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 851 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228491-A1 | METHIONINE ADENOSYLTRANSFERASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | SCINNOHUB PHARMACEUTICAL CO., LTD. (CN) | 2024-07-11 | — | — | US | claimed |
| EP-4332101-A1 | METHIONINE ADENOSYLTRANSFERASE INHIBITOR, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF | Scinnohub Pharmaceutical Co., Ltd (CN) | 2024-03-06 | — | — | EP | claimed |
| WO-2022257351-A1 | POLYDISULFIDE MATERIAL HAVING EXCELLENT OPTICAL PROPERTIES AND PREPARATION METHOD THEREFOR | 大连理工大学 | 2022-12-15 | — | — | WO | claimed |
| EP-3904443-A1 | LIGHT-RESISTANT, HEAT-RESISTANT, AND DURABLE UV ABSORBENT | Miyoshi Oil & Fat Co., Ltd. (JP) | 2021-11-03 | — | — | EP | claimed |
| CN-113272263-A | Glass plate with coating film and composition for forming the same | 日本板硝子株式会社 | 2021-08-17 | — | — | CN | claimed |
| CN-113195611-A | Light-resistant, heat-resistant and durable ultraviolet absorber | 三吉油脂株式会社 | 2021-07-30 | — | — | CN | claimed |
| WO-2020137819-A1 | LIGHT-RESISTANT, HEAT-RESISTANT, AND DURABLE UV ABSORBENT | ミヨシ油脂株式会社 | 2020-07-02 | — | — | WO | claimed |
| CN-111057048-A | Aminopyrazine/pyridine compound, preparation method and application | 如东凌达生物医药科技有限公司 | 2020-04-24 | — | — | CN | claimed |
| EP-2167489-B1 | PYRIMIDINE DERIVATIVES USEFUL AS RAF KINASE INHIBITORS | SUNESIS PHARMACEUTICALS INC (US) | 2017-05-03 | — | — | EP | claimed |
| US-8802657-B2 | Compounds useful as Raf kinase inhibitors | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2014-08-12 | — | — | US | claimed |
| EP-0922030-A1 | ARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES | PFIZER INC. (US) | 1999-06-16 | — | — | EP | claimed |
| EP-0895988-A1 | Arylsulfonylamino hydroxamic acid derivatives | Pfizer Products Inc. (US) | 1999-02-10 | — | — | EP | claimed |
| US-5863949-A | Arylsulfonylamino hydroxamic acid derivatives | PFIZER INC (US) | 1999-01-26 | — | — | US | claimed |
| US-5861510-A | Arylsulfonyl hydroxamic acid derivatives as MMP and TNF inhibitors | PFIZER INC (US) | 1999-01-19 | — | — | US | claimed |
| WO-1998034918-A1 | ARYLSULFONYL HYDROXAMIC ACID DERIVATIVES | PFIZER INC. (US) | 1998-08-13 | — | — | WO | claimed |
| WO-1998007697-A1 | ARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES | PFIZER INC. (US) | 1998-02-26 | — | — | WO | claimed |
| EP-0821671-A1 | ARYLSULFONYL HYDROXAMIC ACID DERIVATIVES AS MMP AND TNF INHIBITORS | PFIZER INC. (US) | 1998-02-04 | — | — | EP | claimed |
| EP-0813520-A1 | ARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES | PFIZER INC. (US) | 1997-12-29 | — | — | EP | claimed |
| WO-1996033172-A1 | ARYLSULFONYL HYDROXAMIC ACID DERIVATIVES AS MMP AND TNF INHIBITORS | PFIZER INC. (US) | 1996-10-24 | — | — | WO | claimed |
| WO-1996027583-A1 | ARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES | PFIZER INC. (US) | 1996-09-12 | — | — | WO | claimed |